EyeGene Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

108.57%

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Internal Auditor

Seok Geun Choi

Chief Executive Officer, Director · since 2024

Myeong Jae Lee

Chief Financial Officer, Director · since 2024

Won Yil Yoo

President, Director · since 2024

Du Sik Kim

Other Non-Executive Director

Gu Woo

Other Non-Executive Director · since 2024

URL

IPO date

Nov 28, 2013

Employees

Domiciled in

Incorporated in

No data to show